Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by CIBC Private Wealth Group LLC

CIBC Private Wealth Group LLC lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% during the 4th quarter, Holdings Channel.com reports. The fund owned 482,830 shares of the medical equipment provider’s stock after selling 14,943 shares during the period. CIBC Private Wealth Group LLC’s holdings in Intuitive Surgical were worth $262,669,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Atala Financial Inc acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $25,000. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical in the fourth quarter valued at $28,000. Summit Securities Group LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at $30,000. Finally, Kohmann Bosshard Financial Services LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $31,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $491.84 on Friday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company has a market cap of $175.18 billion, a price-to-earnings ratio of 76.73, a PEG ratio of 5.85 and a beta of 1.43. The business’s fifty day moving average is $556.28 and its two-hundred day moving average is $532.68.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on ISRG. Piper Sandler reissued an “overweight” rating and issued a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Leerink Partners raised their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Raymond James lifted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. UBS Group increased their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Finally, Truist Financial dropped their price objective on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research note on Monday, March 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.